Risk of idiopathic venous thromboembolism in users of progestagens alone

被引：119

作者：

Vasilakis, C ^{[1
]}

Jick, H ^{[1
]}

Melero-Montes, MD ^{[1
]}

机构：

[1] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA

来源：

LANCET | 1999年 / 354卷 / 9190期

关键词：

D O I：

10.1016/S0140-6736(99)04394-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Data from the WHO Collaborative Study suggest that use of progestagen preparations with therapeutic indications are associated with a significantly increased risk of venous thromboembolism but not stroke or myocardial infarction.

引用

页码：1610 / 1611

页数：2

共 5 条

[1] ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN [J].

BLOEMENKAMP, KWM ;

ROSENDAAL, FR ;

HELMERHORST, FM ;

BULLER, HR ;

VANDENBROUCKE, JP .

LANCET, 1995, 346 (8990) :1593-1596

[2]

FARLEY TMM, 1995, LANCET, V346, P1582

[3] RISK OF IDIOPATHIC CARDIOVASCULAR DEATH AND NONFATAL VENOUS THROMBOEMBOLISM IN WOMEN USING ORAL-CONTRACEPTIVES WITH DIFFERING PROGESTAGEN COMPONENTS [J].

JICK, H ;

JICK, SS ;

GUREWICH, V ;

MYERS, MW ;

VASILAKIS, C .

LANCET, 1995, 346 (8990) :1589-1593

[4] Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications [J].

Poulter, NR ;

Chang, CL ;

Farley, TMM ;

Meirik, O .

LANCET, 1999, 354 (9190) :1610-1610

[5] The risk of venous thromboembolism in users of postcoital contraceptive pills [J].

Vasilakis, C ;

Jick, SS ;

Jick, H .

CONTRACEPTION, 1999, 59 (02) :79-83

← 1 →